Used as a replacement for animal-based protein sources, the market for foods containing plant-based proteins (PBPs) continues to grow across North America. As of now, however, few studies of consumer behaviour focus specifically on the dynamics of this development in Canada and so this study looks at how PBPs fit in the current dietary choices of Canadians. Using data collected through a geographically representative nation-wide survey, the analysis shows that past and current consumption of these products are good indicators of future consumption of PBPs. Relatedly, negative stigma attached to earlier versions of PBPs, sometimes referred to as ‘fake meat’, continues to be an issue with current Canadian consumers. The analysis also demonstrates that personal health and animal/environmental ethics play a significant role in individual decisions to eat PBPs instead of meat. Additionally, issues of availability, affordability and concern over the sensory qualities continue to present barriers to future use.
Purpose: Despite the growing awareness of links between meat consumption and human, animal and environmental health, consumption rates of protein rich plant-based foods (PBFs) in Canada remain relatively low. The purpose of this paper is to better understand how information sources and trust relate to PBFs in Canadians’ diets, and how these variables may factor into closing the commercialization gap for PBFs in Canada. Design/methodology/approach: A geographically representative sample of Canadians (n=410) participated in a 20-minute, online survey. The survey consists of 24 questions covering demographic characteristics, motivations behind current and future food choices, frequency of current PBF consumption, sources of information about PBFs and trust levels of these sources. Findings: Most Canadians get information about PBFs from labels, the internet and family and friends, but only half trust these sources to provide accurate information. Sources of information (e.g. licensed health care professionals) that rank high in trust are only consulted by a minority of respondents. Several information sources (e.g. family and friends) are associated with consumers’ willingness to try new PBFs, whereas other sources (e.g. labels) are associated with Canadians being unlikely to try new PBFs. Originality/value: Understanding the patterns of where Canadians access information about PBFs and what sources of information are trusted can help to strategically place information about PBF qualities among select information sources and to remove some of the information barriers contributing to the PBF commercialization gap.
This article examines how effective quality assurance mechanisms can help address three challenges facing scaling-up efforts in supply chains for complementary foods in Sub-Saharan Africa (SSA): sourcing, market size and consumer trust. We use supply chain analysis to evaluate how stakeholder actions and relationships influence the dynamics of complementary food markets in SSA. We argue that effective signalling of credence attributes via credible quality assurance can contribute to the sustainability of local complementary food supply chains and once established, may contribute to the long-term affordability, accessibility and availability of these foods in SSA. The article concludes by stressing that allocating resources for establishing or further implementing regional and/or state-level quality assurance mechanisms for food safety and quality requires the coordination of stakeholder actions to address food insecurity across SSA.
Ready to Use Therapeutic Foods (RUTFs) are used in international food assistance strategies as a safe and effective way of treating children suffering from severe acute malnutrition (SAM). Though the peanut-based formulation has a proven track record in terms of efficacy in treating SAM around the world, the conventional formulation is not without challenges. Concerns regarding cost, the availability of local ingredients, the presence of aflatoxin, shifting global supply patterns, and dietary appropriateness of the peanut-based RUTF have encouraged researchers to experiment with other lipid sources in formulations. This shift requires not only changes to RUTF formulations, but also changes to supply chain activities. The goal of this review is to first, provide an update on the efficacy of recently trialed non-peanut RUTF formulations in treating SAM in infants and children and second, to review recent UN agency led interventions into local/regional RUTF supply chains and programmatic capacity. Based on published documents (2017–2019), this review flags three significant issues requiring further attention from the international food assistance community: the need for follow-up studies of children treated for SAM with RUTFs in programmatic countries, a regional customization of Community-Based Management of Acute Malnutrition (CMAM) protocols to maximize cost effectiveness and programmatic coverage, and an increase in the number of studies focusing on the acceptability of non-peanut RUTF formulations by the infants and children in low and medium income countries.
The interpretation of risk in governance frameworks for genetically modified (GM) foods is an important component of their design and function. This paper develops the concept of a risk frame to better understand how perceptions of risk, uncertainty, and authority over evidence are considered in governance frameworks for GM foods. It develops a typology of risk frames: the proof of harm, precautious and precaution through experience risk frames. The ‘precaution through experience’ risk frame is an emergent concept offering possible avenues beyond current regulatory standoffs by incorporating both scientific and socio-economic perspectives of risk in deepened deliberative settings. The paper uncovers how varying interpretations of uncertainty and acceptable levels of risk associated with innovative technologies influence the development of public policy within regulatory frameworks for biotechnology.